• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Medical Imaging in the XXI Century: Too much of a good thing?

  • Fri, 9/18/09 - 8:14am
  • 0 Comments
  • 1940 reads
Start Page: 
4
End Page: 
4
Author(s): 

Frank J. Criado
Editor-in-Chief
Vascular Surgery and
Endovascular Intervention;
Union Memorial Hospital/
MedStar Health,
Baltimore, Maryland
frank.criado@medstar.net

Many of us have come to depend on (even demand) the kind of exquisite imaging depicted in Figure 1. Contemporary management of aortic diseases is changing dramatically as it goes through a revolution of sorts, propelled — in a large measure — by the ability to visualize the vascular anatomy with a degree of definition and refinement we would not have thought possible a decade ago. Add to this the remarkable developments in the endovascular technology field and one can explain easily the near-incredible transformation in all the cardiovascular specialties.

We now use this imaging capability for diagnosis, pre-operative assessment and procedure planning, stent-graft device sizing, as well as patient follow-up and surveillance — lifelong. Furthermore, it is clear that the impact of modern medical imaging is being felt much beyond aortic intervention, inducing transformational influence in — essentially — every anatomy-centered area of medicine.

Today, a great number of patients enjoy the advantages of precise diagnosis and treatment with less-invasive technologies in a manner that is increasingly safe and successful. Importantly though and on the downside, these patients are also being exposed to significant doses of radiation over time... So, what’s the problem?

Fazel et al focused on this very issue in a recent study.1 They found that, indeed, “imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation”. Computed tomography scans and nuclear imaging accounted for 75.4% of the cumulative effective dose, and more than 80% of the procedures were done in an outpatient setting. In addition to radiation, economic costs are another source of concern related to the widespread and ever-increasing use of medical imaging in this country.

It was almost too good to be true, wasn’t it? Just when we were finally feeling at the very top of our game in some of the fields where modern imaging has made a world of difference… we are now beginning to hear that perhaps this should be slowed down and that we ought to re-think some of the diagnostic and surveillance strategies…. I for one would not be surprised to see attempts (from various corners) to restrict and/or micro-manage physicians’ ability to order and perform imaging procedures in the near future. From that perspective, it would be in our best interest to become proactive in proposing and implementing reasonable guidelines that experts and professional societies can hopefully agree on — as opposed to impositions coming from outside entities. It may well be our best chance to retain the ability to use advanced imaging modalities in a manner that contributes to the ultimate goal of best patient care but, at the same time, minimizes costs in terms of economic expense and excessive exposure to radiation.

References: 

1. Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849–857.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications